Iron sequestration and anemia of inflammation

Semin Hematol. 2009 Oct;46(4):387-93. doi: 10.1053/j.seminhematol.2009.06.001.

Abstract

Anemia of chronic disease, also called anemia of inflammation, is characterized by hypoferremia due to iron sequestration that eventually results in iron-restricted erythropoiesis. During the last decade, the molecular mechanisms of iron sequestration have been found to center on cytokine-stimulated overproduction of the iron-regulatory hormone hepcidin. The inflammatory cytokine interleukin-6 (IL-6) is a particularly prominent inducer of hepcidin, but other cytokines are likely to contribute as well. Hepcidin excess causes the endocytosis and proteolysis of the sole known cellular iron exporter, ferroportin, trapping iron in macrophages and iron-absorbing enterocytes. The supply of iron to hemoglobin synthesis becomes limiting, eventually resulting in anemia. Depending on the details of the underlying disease, other inflammation-related mechanisms may also contribute to anemia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anemia / drug therapy
  • Anemia / etiology*
  • Anemia / metabolism
  • Anemia / physiopathology
  • Antimicrobial Cationic Peptides / metabolism
  • Biological Transport
  • Cation Transport Proteins / metabolism
  • Enterocytes / metabolism
  • Erythropoiesis* / drug effects
  • Hematinics / therapeutic use
  • Hemoglobins / metabolism
  • Hepcidins
  • Humans
  • Inflammation / complications*
  • Inflammation / metabolism
  • Inflammation / physiopathology
  • Interleukin-6 / metabolism
  • Iron / metabolism*
  • Macrophages / metabolism

Substances

  • Antimicrobial Cationic Peptides
  • Cation Transport Proteins
  • HAMP protein, human
  • Hematinics
  • Hemoglobins
  • Hepcidins
  • IL6 protein, human
  • Interleukin-6
  • metal transporting protein 1
  • Iron